Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalBone Marrow PurgingTissue DonorsBusulfanHematopoietic Stem CellsCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHistocompatibility TestingBone Marrow DiseasesHistocompatibilityCombined Modality TherapyTransplantation, IsogeneicHematopoiesisBone Marrow ExaminationTreatment OutcomeKidney TransplantationRecurrenceMice, Inbred C57BLLeukemia, Myeloid, AcuteRadiation ChimeraTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsImmunosuppressive AgentsRemission InductionGraft RejectionLeukemia, MyeloidT-LymphocytesLymphoma, Non-HodgkinHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologySurvival AnalysisGraft vs Host ReactionColony-Forming Units AssayStem Cell TransplantationAcute DiseaseImmunosuppressionLymphocyte DepletionLeukocyte TransfusionHeart TransplantationMyelodysplastic SyndromesChimeraSevere Combined ImmunodeficiencyHLA AntigensHematologic DiseasesLeukocyte CountRetrospective StudiesFlow CytometryActuarial AnalysisSurvival RateGranulocyte Colony-Stimulating FactorCell DifferentiationDisease-Free SurvivalCyclosporineCarmustineEtoposideLung TransplantationLymphocyte TransfusionFollow-Up StudiesCytarabineCells, CulturedBone DensityPancytopeniaSpleenNuclear FamilyMelphalanPrognosisAntigens, CD34Multiple MyelomaMice, Inbred BALB COrgan TransplantationLymphomaGraft vs Tumor EffectCytomegalovirus InfectionsGraft vs Leukemia EffectPeripheral Blood Stem Cell TransplantationImmunophenotypingBlood CellsBone ResorptionHodgkin DiseaseGranulocytesAntibodies, MonoclonalFatal Outcome